Showing 7091-7100 of 10011 results for "".
- MedXSafe Phone App Launches for STD Awarenesshttps://practicaldermatology.com/news/20130117-medxsafe_phone_app_launches_for_std_awareness/2459634/Giffen Solutions Inc. released MedXSafe, a new feature to its popular MedXCom Patient platform. Doctors, college health centers, or local health clinics can test for STDs and sign off on MedXSafe that a patient is free of STDs as
- Lancer Skincare Launches At-Home Producthttps://practicaldermatology.com/news/20130117-lancer_skincare_launches_at-home_product/2459635/The Lancer Skincare collection now includes the Microcurrent Powerboost, a hand-held device to help tone, tighten, and correct imbalances in the skin. According to the company, the Microcurrent Powerboost allows daily skincare products to b
- CeraVe Sun Care Partners with Olympic Swimmer Rebecca Sonihttps://practicaldermatology.com/news/20130115-cerave_sun_care_partners_with_olympic_swimmer_rebecca_soni/2459637/CeraVe Sun Care, a new line by Valeant Pharmaceuticals North America LLC, will partner with swimmer Rebecca Soni, six-time US Olympic medalist and World Record holder in the 100- and 200-meter breaststroke, as the face of the brand in 2013. The CeraVe
- Women's Dermatologic Society Event January 15https://practicaldermatology.com/news/20130111-womens_dermatologic_society_event_january_15/2459640/The Women's Dermatologic Society, sponsored by Glytone, will hold a “Look Before You Leap” Media Day 2013 on January 15, a series of desk-side appointments with the editorial community focusing on the pitfalls, complications, problems, and myths surrounding skin care and dermatology topics. Founded
- Jan Marini Skin Research Launches Regeneration Boosterhttps://practicaldermatology.com/news/20130110-jan_marini_skin_research_launches_regeneration_booster/2459643/Jan Marini Skin Research released its all-new Regeneration Booster. Cycloastragenol, TGF Beta-1, multiple beneficial growth factors, and four advanced anti-aging peptides are combined with coenzyme Q10 and additional antioxidants to reduce the a
- Allergan Acquires SkinMedicahttps://practicaldermatology.com/news/20121221-allergan_acquires_skinmedica/2459654/Allergan, Inc. completed the acquisition of SkinMedica, Inc. Under the terms of the agreement, which was first announced on November 16, 2012, Allergan paid approximately $350 million (subject to certain adjustments) for the business, which inclu
- Results Released from Phase 2 Trial of IMO-3100 in Plaque Psoriasishttps://practicaldermatology.com/news/20121219-results_released_from_phase_2_trial_of_imo-3100_in_plaque_psoriasis/2459655/In a recent study, Idera Pharmaceuticals reported that 48 percent of patients with moderate-to-severe plaque psoriasis (12 of 25) treated with IMO-3100, a selective antagonist of Toll-like Receptors (TLRs) 7 and 9, demonstrated improvements in
- Glytone Announces Antioxidant Kit Specialhttps://practicaldermatology.com/news/20121217-glytone_announces_antioxidant_kit_special/2459657/Glytone currently offers two limited-edition antioxidant kits, featuring a selection of three products from the Glytone antioxidant range. One version includes Anti-aging Serum, Anti-aging Cream, and Anti-aging Eye Cream while the other featur
- Galderma Acquires Spirighttps://practicaldermatology.com/news/20121213-galderma_acquires_spirig/2459659/Galderma Pharma S.A. and Spirig Pharma A.G. entered into a definitive agreement under which Galderma will acquire Spirig. Spirig's products treat conditions such as solar damage, skin barrier function impairment, and actinic keratosis. Leading br
- Valeant, Galderma Revise Agreement Termshttps://practicaldermatology.com/news/20121210-valeant_galderma_revise_agreement_terms/2459661/Valeant Pharmaceuticals International, Inc. reached agreement on terms of a revised North American aesthetics arrangement with Galderma S.A. Under the terms, Galderma will continue to supply Restylane and Perlane to Valeant, under the terms and co